inHEART

inHEART is a deep tech healthcare start-up founded in 2017 and based in Pessac, France, with a subsidiary in Boston, USA. The company focuses on developing advanced AI-driven software solutions for cardiac care, particularly for heart rhythm disorders and cardiac ablation procedures. Their key innovation is the world's first AI-enabled digital twin of the heart, which creates detailed, interactive 3D heart models from cardiac CT or MR images. This technology helps physicians optimize treatment strategies tailored to each patient's unique anatomy. The company's offerings span the entire cardiac care continuum, including early screening, disease detection, and therapeutic support. Their AI-driven predictive models assist in forecasting risks such as heart failure and sudden cardiac death, enabling personalized therapy and informed clinical decision-making. inHEART collaborates with research centers and partners with organizations to enhance their AI capabilities. Their solutions are designed for cardiologists and healthcare providers, aiming to improve the efficiency and effectiveness of cardiac interventions, ultimately benefiting patients with cardiac diseases.

• Employees 40
• Founded 2017
• Annual Revenue $4500000
• Total Funding $4157490